Results 21 to 30 of about 77,745 (275)

Treatment of headache in aneurysmal subarachnoid hemorrhage: Multimodal approach

Interdisciplinary Neurosurgery, 2020
Sudden severe headache is a cardinal symptom and the most common complaint amongst patients presenting with aneurysmal subarachnoid hemorrhage. The multifactorial etiology of these headaches makes pharmacotherapy problematic.
Garrett B. Hile, Aaron M. Cook
doaj   +1 more source

Intravenous tPA therapy does not worsen acute intracerebral hemorrhage in mice [PDF]

, 2013
Tissue plasminogen activator (tPA) is the only FDA-approved treatment for reperfusing ischemic strokes. But widespread use of tPA is still limited by fears of inadvertently administering tPA in patients with intracerebral hemorrhage (ICH).
Emiri Mandeville, Cianchetti, Flor A., Ken Arai, van Leyen, Klaus, Frieder Schlunk (280822), Eng H. Lo (112154), Kazim Yigitkanli, Chris B Schaffer, Mandeville, Emiri, Yigitkanli, Kazim, Xiaoying Wang, Nathanael L Rosidi, Chris B. Schaffer (155846), Arne Lauer (280824), Fan, Xiang, Eng H Lo, Helmuth Steinmetz (149409), Rosidi, Nathanael L., Xiang Fan (280830), Schlunk, Frieder, Frieder Schlunk, Flor A. Cianchetti (280825), Wang, Xiaoying, Christian Foerch (149410), Flor A Cianchetti, Kazim Yigitkanli (280829), Arai, Ken, Förch, Christian, Leyen, Klaus van, Lo, Eng H., Foerch, Christian, Xiang Fan, Schaffer, Chris B., Ken Arai (280828), Klaus van Leyen, Helmuth Steinmetz, Emiri Mandeville (280827), Steinmetz, Helmuth, Christian Foerch, Lo, Eng, Arne Lauer, Nathanael L. Rosidi (280821), Xiaoying Wang (30853), Klaus van Leyen (280831), Lauer, Arne   +44 more
core   +1 more source

Incidence and Outcome of Aneurysmal Subarachnoid Hemorrhage: The Swiss Study on Subarachnoid Hemorrhage (Swiss SOS).

, 2021
BACKGROUND AND PURPOSE The purpose of this study was to assess nationwide incidence and outcomes of aneurysmal subarachnoid hemorrhage (aSAH). The Swiss SOS (Swiss Study on Subarachnoid Hemorrhage) was established in 2008 and offers the unique ...
Finkenstädt, S., Starnoni, Daniele, Daniel, R.T., Schatlo, Bawarjan, Mendes Pereira, Vitor, D Alonzo, Donato, Stienen, M.N., Diepers, Michael, Landolt, H., Remonda, Luca, Remonda, L., Sarrafzadeh-Khorassani, Asita Simone, Z'Graggen, Werner, Goldberg, Johannes, Gasche, Yvan, Keller, Emanuela, Schöni, D., Kulcsar, Z., Maldaner, N., Bijlenga, Philippe Alexandre Pierre, Sarrafzadeh, A., Starnoni, D., Mendes Pereira, V., Rohde, V., Mariani, L., Bijlenga, P., Venier, Alice, Hildebrandt, G., Mostaguir, Khaled, Bernays, René, Perren, Fabienne, Fung, Christian, Schaller, Karl Lothard, Corniola, Marco, Marbacher, Serge, Regli, Luca, Bervini, David, Sailer, Martin, Gralla, Jan, Robert, T., Weyerbrock, Astrid, Kerkeni, H., Roethlisberger, Michel, Eisenring, Christian, Maduri, R., Mostaguir, K., Ahlborn, P., Roethlisberger, M., Z'Graggen, W., Schöni, Daniel, Diepers, M., Baumann, F., Burkhardt, Jan-Karl, Schaller, K., Levivier, M., Eisenring, C., Seule, Martin, Fandino, Javier, Venier, A., Ferrari, A., Jakob, Stephan M., Levivier, Marc, Landolt, Hans, Keller, E., Ferrari, Andrea, Gralla, J., Stienen, Martin N, Zumofen, Daniel, Ahlborn, Peter, Woernle, Christoph, Marbacher, S., Hildebrandt, Gerhard, Burkhardt, J.K., Jakob, Stephan M, Guzman, R., Raabe, Andreas, Sailer, M., Fandino, J., Schaller, Karl, Finkenstädt, Sina, Perren, F., Woernle, Kerstin, Bijlenga, Philippe, Goldberg, J., Rohde, Veit, Gasche, Y., Fathi, A.R., Robert, Thomas, Dan-Ura, H., Jakob, S.M., Weyerbrock, A., Kerkeni, Hassen, Reinert, M., Bernays, R., Bervini, D., Regli, L., Beck, Jürgen, Woernle, C., Nevzati, E., Smoll, N.R., Fathi, Ali R, Seule, M., Daniel, Roy Thomas, Sarrafzadeh, Asita, D Alonzo, D., Zumofen, D., Dan-Ura, Hiroki, Fung, C., Beck, J., Woernle, K., Raabe, A., Maldaner, Nicolai, Kulcsar, Zsolt, Corniola, M., Mariani, Luigi, Guzman, Raphael, Schatlo, B., Reinert, Michael, Maduri, Rodolfo, Nevzati, Edin, Baumann, Fabian, Smoll, Nicolas R   +121 more
core   +1 more source

Risk factors for mortality after subarachnoid hemorrhage: a retrospective observational study [PDF]

Revista Brasileira de Anestesiologia
Background and objectives: Subarachnoid hemorrhage is an important cause of morbidity and mortality. The aim of the study was to determine predictors of mortality among patients with subarachnoid hemorrhage hospitalized in an Intensive Care Unit ...
Matthaios Papadimitriou-Olivgeris, Anastasia Zotou, Kyriaki Koutsileou, Diamanto Aretha, Maria Boulovana, Theofanis Vrettos, Christina Sklavou, Markos Marangos, Fotini Fligou   +8 more
doaj   +4 more sources

Subarachnoid hemorrhage in the emergency department

International Journal of Emergency Medicine, 2021
Background Subarachnoid hemorrhage accounts for more than 30,000 cases of stroke annually in North America and encompasses a 4.4% mortality rate. Since a vast number of subarachnoid hemorrhage cases present in a younger population and can range from ...
Sima Patel, Amay Parikh, Okorie Nduka Okorie   +2 more
doaj   +1 more source

Apolipoprotein E polymorphism and neuropsychological outcome following subarachnoid haemorrhage [PDF]

, 2004
Objectives–To investigate the association between APOE genotype and cognitive and emotional outcome following spontaneous subarachnoid haemorrhage (SAH).Materials and methods–Neuropsychological assessments were conducted with 70 SAH survivors derived ...
Morris, Paul Graham; id_orcid, Nicoll, James A R, Dunn, L.T., Wilson, J T Lindsay, Dunn, Laurence T, Nicoll, J.A., Wilson, J.T., Morris, P.G.   +7 more
core   +1 more source

Advances in Subarachnoid Hemorrhage [PDF]

Stroke, 2006
Although subarachnoid hemorrhage (SAH) comprises only 1% to 7% of all strokes,1 the loss of productive life years in the general population from SAH is comparable to that of cerebral infarction2 because of the relatively young age of onset and poor outcome in SAH.1,3,4 However, unlike other stroke subtypes, the incidence of SAH exhibits little ...
Valery L, Feigin, Max, Findlay
openaire   +2 more sources

Prophylactic management of cerebral vasospasm with clazosentan in real clinical practice: a single-center retrospective cohort study

Frontiers in Neurology
IntroductionClazosentan, a selective endothelin receptor subtype A antagonist, reduces vasospasm-related morbidity and all-cause mortality following aneurysmal subarachnoid hemorrhage (SAH) in the Japanese population, as demonstrated by a recent ...
Hiroyuki Sakata, Hiroyuki Sakata, Atsushi Kanoke, Hiroki Uchida, Shinya Haryu, Shunsuke Omodaka, Naoto Kimura, Masahiro Yoshida, Kuniyasu Niizuma, Kuniyasu Niizuma, Kuniyasu Niizuma, Kuniyasu Niizuma, Teiji Tominaga, Teiji Tominaga, Hidenori Endo, Hidenori Endo   +15 more
doaj   +1 more source

Acute management of poor condition subarachnoid hemorrhage patients

, 2012
Poor condition subarachnoid hemorrhage (SAH) patients present a high mortality and morbidity. In this study, we reviewed the acute interventional (surgical and endovascular) management of 109 SAH-poor condition patients, who were treated as early as ...
Archavlis, Eleftherios, Carvi y Nievas, Mario N.   +1 more
core   +1 more source

The pivotal role of microglia in injury and the prognosis of subarachnoid hemorrhage

Neural Regeneration Research
Subarachnoid hemorrhage leads to a series of pathological changes, including vascular spasm, cellular apoptosis, blood–brain barrier damage, cerebral edema, and white matter injury. Microglia, which are the key immune cells in the central nervous system,
Wenjing Ning, Shi Lv, Qian Wang, Yuzhen Xu   +3 more
doaj   +1 more source